NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nerai Bioscience AG

Nerai Bioscience AG

Private
ZurichHealthcare & Life Scienceshttps://nerai.bio/

Last Round

Seed

May 1, 2025

Total Funding Raised

$4.5M

Company Overview

Nerai Bioscience AG is a biotechnology company that pioneers novel, highly personalized CRISPR proteins to deliver cures for genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

genome editingCRISPRgene therapyAI drug discoveryrare disease therapyprotein engineeringprecision gene editinggenerative biologybespoke genome editorsdirected evolutionhigh-throughput screeningbiopharma partnershipsdrug discovery platformplatform licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nerai Bioscience AG Comparables

Compare Nerai Bioscience AG with similar companies based on industry and business-model similarity.

Nerai Bioscience AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Nerai Bioscience AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Vincent Forster

CEO and co-founder

Founding Team

Nerai Bioscience AG Investors

Notable investors and investment history

Nerai Bioscience AG investors
InvestorRounds
Gebert Rüf StiftungSeed
KickfundSeed
Swiss National Science FoundationSeed
Venture KickSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 61% MoM, reaching 2.4K.

  • Sep 6, 2025

    Grew 200% QoQ from 2 to 6 employees.

View all signals

Nerai Bioscience AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nerai Bioscience AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nerai Bioscience AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range8
Year Founded2019
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.